06/05/2026
ASCO 2026 showcased remarkable advances across oncology, but several broader trends stood out beyond the individual study results.
In this article, Cromos Pharma CEO Vlad Bogin, MD, FACP shares five developments that he believes could have the greatest impact on the future of cancer research and clinical development.
Read the article: https://cromospharma.com/asco-2026-five-trends-that-caught-my-attention/